MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 230 filers reported holding MEDICINES CO in Q1 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,445,000 | -8.9% | 28,900 | -33.6% | 0.03% | 0.0% |
| Q2 2019 | $1,586,000 | +95.6% | 43,500 | +50.0% | 0.03% | -40.0% |
| Q1 2019 | $811,000 | +29.6% | 29,000 | +70.1% | 0.04% | -15.1% |
| Q2 2018 | $626,000 | +7.9% | 17,050 | -3.1% | 0.05% | -7.0% |
| Q1 2018 | $580,000 | +18.9% | 17,600 | -1.4% | 0.06% | +11.8% |
| Q4 2017 | $488,000 | -32.4% | 17,850 | -8.5% | 0.05% | -32.9% |
| Q3 2017 | $722,000 | -2.6% | 19,500 | 0.0% | 0.08% | -13.6% |
| Q2 2017 | $741,000 | -29.5% | 19,500 | -9.3% | 0.09% | -37.1% |
| Q1 2017 | $1,051,000 | – | 21,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |